Anatomic and Management Differences Between Intermediate and Complete AVSD

Anatomic Distinctions

Intermediate AVSD represents a transitional form between partial and complete AVSD, with incomplete atrial and ventricular septal defects and/or incomplete abnormalities of the common atrioventricular valve, whereas complete AVSD has a septal defect extending into both the interatrial and interventricular septum with a single common atrioventricular valve orifice, according to the American College of Cardiology 1

Partial AVSD is characterized by a primum ASD component only, with anterior and posterior bridging leaflets fused centrally, creating separate left and right-sided orifices, as described by the European Heart Journal 2, 1
Complete AVSD has both ASD and VSD components present, with a single common atrioventricular valve orifice without central fusion of bridging leaflets, and a septal defect at the crux of the heart extending into both interatrial and interventricular septum, according to the European Heart Journal 2, 1

Complete AVSD requires repair typically before 6 months of age to prevent irreversible pulmonary vascular disease, as recommended by the American College of Cardiology 1
Surgery is indicated for complete AVSD with a net left-to-right shunt, PA systolic pressure <50% systemic, and pulmonary vascular resistance <1/3 systemic, according to the American College of Cardiology 1
Intermediate AVSD requires surgical closure with significant volume overload of the right ventricle, as indicated by the European Heart Journal 2

Both intermediate and complete AVSD require lifelong follow-up at specialized adult congenital heart disease centers, with surveillance focused on residual shunts, AV valve dysfunction, LVOT obstruction, and arrhythmias, as recommended by the European Heart Journal 2
Left AV valve regurgitation or stenosis, LVOT obstruction, and development of heart block are common late complications, according to Circulation 3 and the American College of Cardiology 1
Follow-up intervals should be every 24-36 months for patients with no hemodynamic abnormalities, every 24 months for patients with mild abnormalities, every 6-12 months for patients with moderate abnormalities, and every 3-6 months for patients with severe abnormalities, as recommended by the American College of Cardiology 1
Surveillance should include transthoracic echocardiography, ECG monitoring, exercise testing, and cardiac MRI when necessary, according to Circulation 3 and the American College of Cardiology 1

AVSDs represent 4-5% of congenital heart defects and are classified by anatomic variations involving a primum ASD, inlet VSD, and common atrioventricular valve, according to the American College of Cardiology 4
Partial AVSD is characterized by a primum ASD component only with typically a cleft left atrioventricular valve, with separate left and right-sided orifices created by central fusion of bridging leaflets, as described by the European Heart Journal 5, 6
Complete AVSD involves both ASD and VSD components with a common atrioventricular valve and single orifice, with septal defect extending into both interatrial and interventricular septum, according to the American College of Cardiology and European Heart Journal 4, 6

Unoperated patients may present with findings of ASD, VSD, AV valve regurgitation, LVOT obstruction, or pulmonary arterial hypertension with cyanosis, as reported in Circulation 7
Apical systolic murmur indicates residual mitral regurgitation or subaortic obstruction in repaired patients, according to Circulation 7
Single loud second heart sound with no murmur suggests severe pulmonary arterial hypertension, as described in Circulation 7

Surgery for primary repair or closure of residual shunts is recommended when there is net left-to-right shunt (Qp:Qs ≥1.5:1), PA systolic pressure <50% systemic, and pulmonary vascular resistance <1/3 systemic, according to the American College of Cardiology 4, 8
The American College of Cardiology recommends surgery for severe left atrioventricular valve regurgitation per guideline-directed medical therapy indications for mitral regurgitation 4, 8
Symptomatic patients with moderate to severe AV valve regurgitation should undergo valve surgery, preferably AV valve repair, as recommended by the European Heart Journal 5, 6

Lifelong regular follow-up of all patients (operated and unoperated) is recommended at specialized adult congenital heart disease centers, according to the European Heart Journal 5, 6
The American College of Cardiology recommends surveillance intervals by physiological stage, with Stage A (no hemodynamic abnormalities) requiring follow-up every 24-36 months with ECG and TTE 4, 8